Treatment–Refractory Schizophrenia [electronic resource] : A Clinical Conundrum /
Buckley, Peter F.editor.
Gaughran, Fiona.editor.
Schizophrenia is often associated with an inadequate response to pharmacological and non-pharmacological treatments. How to treat patients who have an unsatisfactory response to anti-psychotics, including clozapine - which is unequivocally the most powerful antipsychotic medication for this recalcitrant population  - remains a clinical conundrum. A range of adjunctive medications have been tried with mixed results; there has also been renewed interest in the role of neuromodulatory strategies, electroconvulsive therapy, and cognitive and vocational approaches. Perhaps a bright spot for the future lies in the evolution of pharmacogenetic approaches for individualized care.   In this book, leading experts from Europe, Australia and the Americas provide a timely appraisal of treatments for the most severely ill schizophrenia patients. This clinically focused  book is informed by the latest research on the neurobiology and treatment of schizophrenia. It is comprehensive in scope, covering current treatment options, various add-on approaches, and a range of psychosocial treatments. The contributors are respected experts who have combined their clinical experience with cutting-edge research to provide readers with authoritative information on fundamental aspects of clinical care for schizophrenia.
Description based upon print version of record.
Includes bibliographical references at the end of each chapters and index.
Definitions and scope of treatment-refractory schizophrenia -- Biology of schizophrenia: Is treatment-refractoriness synonymous with severity of illness -- Evolution of refractoriness -- Medical and psychiatric comorbidities: Complicating treatment expectations -- Overview of pharmacologic treatments and guidelines -- Clozapine: Gold standard treatment for refractory schizophrenia: Now or never -- Augmenting clozapine and other antipsychotic medications: Pharmacologic choices and differential outcomes -- Augmenting clozapine therapy: Emerging neuromodulatory strategies -- Cognitive remediation for refractory schizophrenia -- Psychological and familial therapies for refractory schizophrenia -- Vocational performance of patients with chronic schizophrenia -- Refractory schizophrenia and the criminal justice system: A failure of continuity of care and a real challenge -- Personalized medicine: A ‘game changer’ in the care of patients with treatment-refractory schizophrenia?
Schizophrenia is often associated with an inadequate response to pharmacological and non-pharmacological treatments. How to treat patients who have an unsatisfactory response to anti-psychotics, including clozapine - which is unequivocally the most powerful antipsychotic medication for this recalcitrant population  - remains a clinical conundrum. A range of adjunctive medications have been tried with mixed results; there has also been renewed interest in the role of neuromodulatory strategies, electroconvulsive therapy, and cognitive and vocational approaches. Perhaps a bright spot for the future lies in the evolution of pharmacogenetic approaches for individualized care.   In this book, leading experts from Europe, Australia and the Americas provide a timely appraisal of treatments for the most severely ill schizophrenia patients. This clinically focused  book is informed by the latest research on the neurobiology and treatment of schizophrenia. It is comprehensive in scope, covering current treatment options, various add-on approaches, and a range of psychosocial treatments. The contributors are respected experts who have combined their clinical experience with cutting-edge research to provide readers with authoritative information on fundamental aspects of clinical care for schizophrenia.
Psychiatry.
Clinical psychology.
Psychiatry.
Clinical Psychology.